Clinical Trial Update: Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating low-dose ticagrelor in Chinese acute coronary syndrome patients undergoing PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN